Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 1707
TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228638(US9345793, 19 | US9744252, Example 19)
Affinity DataIC50: 3nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228637(US9345793, 18 | US9744252, Example 18)
Affinity DataIC50: 3nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228634(US9345793, 15 | US9744252, Example 15)
Affinity DataIC50: 5nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228635(US9345793, 16 | US9744252, Example 16)
Affinity DataIC50: 6nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228639(US9345793, 20 | US9744252, Example 20)
Affinity DataIC50: 7nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228632(US9345793, 13 | US9744252, Example 13)
Affinity DataIC50: 7nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228631(US9345793, 12 | US9744252, Example 12)
Affinity DataIC50: 8nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228626(US9345793, 7 | US9744252, Example 7)
Affinity DataIC50: 11nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228630(US9345793, 11 | US9744252, Example 11)
Affinity DataIC50: 14nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228627(US9345793, 8 | US9744252, Example 8)
Affinity DataIC50: 14nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228629(US9345793, 10 | US9744252, Example 10)
Affinity DataIC50: 15nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228633(US9345793, 14 | US9744252, Example 14)
Affinity DataIC50: 15nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228625(US9345793, 6 | US9744252, Example 6)
Affinity DataIC50: 16nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228624(US9345793, 5 | US9744252, Example 5)
Affinity DataIC50: 16nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228622(US9345793, 3 | US9744252, Example 3)
Affinity DataIC50: 20nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228628(US9345793, 9 | US9744252, Example 9)
Affinity DataIC50: 21nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228621(US9345793, 2 | US9744252, Example 2)
Affinity DataIC50: 29nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228636(US9345793, 17 | US9744252, Example 17)
Affinity DataIC50: 35nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228623(US9345793, 4 | US9744252, Example 4)
Affinity DataIC50: 84nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetIntegrin alpha-IIb(Human)
Piramal Imaging

US Patent
LigandPNGBDBM228620(US9345793, 1 | US9744252, Example 1)
Affinity DataIC50: 101nMAssay Description:Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent